FI934857A0 - Foerriktning av bindningspar in vivo - Google Patents
Foerriktning av bindningspar in vivoInfo
- Publication number
- FI934857A0 FI934857A0 FI934857A FI934857A FI934857A0 FI 934857 A0 FI934857 A0 FI 934857A0 FI 934857 A FI934857 A FI 934857A FI 934857 A FI934857 A FI 934857A FI 934857 A0 FI934857 A0 FI 934857A0
- Authority
- FI
- Finland
- Prior art keywords
- vivo
- binding
- vivo binding
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
- A61K47/6897—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Nanotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Optics & Photonics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84645392A | 1992-03-04 | 1992-03-04 | |
PCT/US1993/001858 WO1993017707A1 (en) | 1992-03-04 | 1993-03-03 | In vivo binding pair pretargeting |
Publications (2)
Publication Number | Publication Date |
---|---|
FI934857A0 true FI934857A0 (fi) | 1993-11-03 |
FI934857A FI934857A (fi) | 1993-12-03 |
Family
ID=25297986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI934857A FI934857A (fi) | 1992-03-04 | 1993-11-03 | Foerriktning av bindningspar in vivo |
Country Status (7)
Country | Link |
---|---|
US (2) | US5578289A (fi) |
EP (1) | EP0590109A4 (fi) |
JP (1) | JPH06507918A (fi) |
AU (1) | AU663582B2 (fi) |
CA (1) | CA2107558A1 (fi) |
FI (1) | FI934857A (fi) |
WO (1) | WO1993017707A1 (fi) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5688488A (en) * | 1989-04-03 | 1997-11-18 | Purdue Research Foundation | Composition and method for tumor imaging |
WO1996000087A2 (en) * | 1994-06-24 | 1996-01-04 | Akzo Nobel N.V. | Kit for pretargeting and novel pretargeting conjugates |
JP2001512480A (ja) * | 1997-02-19 | 2001-08-21 | セントコア,インコーポレイテッド | 持続的薬物送達およびそれに有用な組成物 |
WO1999036105A2 (en) * | 1998-01-16 | 1999-07-22 | Mca Development B.V. | USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE |
CA2448995A1 (en) * | 2003-11-12 | 2005-05-12 | James Keenan | Device and method for attracting diseased cells and foreign substances |
US20070009427A1 (en) * | 2005-07-06 | 2007-01-11 | Syud Faisal A | Compounds and methods for enhanced delivery to disease targets |
US20070009428A1 (en) * | 2005-07-06 | 2007-01-11 | Syud Faisal A | Compounds and methods for enhanced delivery to disease targets |
US9557635B2 (en) * | 2007-10-18 | 2017-01-31 | Gearbox, Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US8227204B2 (en) * | 2007-10-18 | 2012-07-24 | The Invention Science Fund I, Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US8684898B2 (en) * | 2007-10-18 | 2014-04-01 | The Invention Science Fund I Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US8164074B2 (en) * | 2007-10-18 | 2012-04-24 | The Invention Science Fund I, Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US8529426B2 (en) | 2007-10-18 | 2013-09-10 | The Invention Science Fund I Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US8168958B2 (en) * | 2007-10-18 | 2012-05-01 | The Invention Science Fund I, Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US20090104113A1 (en) * | 2007-10-18 | 2009-04-23 | Searete Llc | Ionizing-radiation-responsive compositions, methods, and systems |
GB2453860B (en) | 2007-10-18 | 2011-03-16 | Searete Llc | Ionizing-radiation-responsive compositions,methods and systems |
JP2011504485A (ja) | 2007-11-21 | 2011-02-10 | ファーマクシス リミテッド | Ssao/vap−1のハロアリルアミン阻害剤およびその用途 |
US11054430B2 (en) | 2015-07-08 | 2021-07-06 | Defined Diagnostics, Llc | Compounds and methods for the detection of methotrexate |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4002532A (en) * | 1974-10-21 | 1977-01-11 | Weltman Joel K | Enzyme conjugates |
GB1595101A (en) * | 1977-03-15 | 1981-08-05 | Hoffmann La Roche | Enzyme modifier immunoassay |
US4468469A (en) * | 1981-11-04 | 1984-08-28 | Miles Laboratories, Inc. | Substituted phenylacetic acids and salts as TBP blocking agents in iodothyronine immunoassays |
FR2523445A1 (fr) * | 1982-03-17 | 1983-09-23 | Sanofi Sa | Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues |
US4661347A (en) * | 1982-11-12 | 1987-04-28 | Scripps Clinic | Cytotoxic compositions |
US4975278A (en) * | 1988-02-26 | 1990-12-04 | Bristol-Myers Company | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
AU633867B2 (en) * | 1989-02-02 | 1993-02-11 | Eli Lilly And Company | Delivery of cytotoxic agents |
ATE177321T1 (de) * | 1989-12-11 | 1999-03-15 | Immunomedics Inc | Verfahren zum aufspüren von diagnostischen oder therapeutischen mitteln durch antikörper |
CA2005162A1 (en) * | 1989-12-11 | 1991-06-11 | Hans J. Hansen | Method for antibody targeting of diagnostic or therapeutic agents |
-
1993
- 1993-03-03 EP EP93906276A patent/EP0590109A4/en not_active Ceased
- 1993-03-03 WO PCT/US1993/001858 patent/WO1993017707A1/en not_active Application Discontinuation
- 1993-03-03 US US08/140,186 patent/US5578289A/en not_active Expired - Fee Related
- 1993-03-03 AU AU37368/93A patent/AU663582B2/en not_active Ceased
- 1993-03-03 JP JP5515830A patent/JPH06507918A/ja active Pending
- 1993-03-03 CA CA002107558A patent/CA2107558A1/en not_active Abandoned
- 1993-11-03 FI FI934857A patent/FI934857A/fi unknown
-
1995
- 1995-05-30 US US08/452,938 patent/US5807534A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH06507918A (ja) | 1994-09-08 |
EP0590109A4 (en) | 1995-04-19 |
US5578289A (en) | 1996-11-26 |
WO1993017707A1 (en) | 1993-09-16 |
US5807534A (en) | 1998-09-15 |
CA2107558A1 (en) | 1993-09-05 |
EP0590109A1 (en) | 1994-04-06 |
FI934857A (fi) | 1993-12-03 |
AU663582B2 (en) | 1995-10-12 |
AU3736893A (en) | 1993-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69410636D1 (de) | Bindungsbestimmung | |
DE69513301D1 (de) | Snowboardbindung | |
DE69532497D1 (de) | Snowboardbindung | |
ATA145192A (de) | Ski | |
FI934857A0 (fi) | Foerriktning av bindningspar in vivo | |
ATA34893A (de) | Snowboardbindung | |
NO175965C (no) | Skibinding | |
ATA112295A (de) | Snowboardbindung | |
ATA36890A (de) | Skibindung | |
DE59509523D1 (de) | Snowboardbindung | |
DE59501537D1 (de) | Skibindung | |
AT399660B (de) | Ski | |
ATA229993A (de) | Skibindung | |
ATA90892A (de) | Ski ski | |
FR2738529B1 (fr) | Reliure personnalisable | |
FI934026A (fi) | Proteinframstaellning av in vivo odlade odoedliga celler | |
NO963313D0 (no) | Alpin parski | |
ATA146792A (de) | Skibindung | |
FI1916U1 (fi) | Anordning foer reglering av cirkelsaogsklingors in boerdes avstaond | |
KR960007143U (ko) | 카드겸용 화투 | |
SE9400030D0 (sv) | Skidlås | |
IT229203Y1 (it) | Gocciolato in marmoresina | |
FI1691U1 (fi) | Hopsaettningsmaskin foer lastpallsben | |
ATA3594A (de) | Snowboard-bindung | |
FI924722A (fi) | In situ-foerfarande foer foerlaengning av lagringsbestaendighet av oemtaoligaprodukter |